Clinical Trial Update: Caphosol in Oral Mucositis Due to Targeted Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Caphosol for oral mucositis caused by targeted cancer therapies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Caphosol

Snippet

Sponsor: Impaqtt Foundation | Conditions: Oral Complaints, Renal Cell Carcinoma | Phase 3 | Status: COMPLETED